rs121908818
Variant summary
Our verdict is Likely pathogenic. The variant received 7 ACMG points: 7P and 0B. PM2PP3_StrongPP5
The NM_017849.4(TMEM127):c.158G>C(p.Trp53Ser) variant causes a missense change. The variant allele was found at a frequency of 0.00000125 in 1,603,718 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. W53C) has been classified as Uncertain significance.
Frequency
Consequence
NM_017849.4 missense
Scores
Clinical Significance
Conservation
Publications
- hereditary pheochromocytoma-paragangliomaInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- pheochromocytomaInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
- renal cell carcinomaInheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 7 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| TMEM127 | NM_017849.4 | c.158G>C | p.Trp53Ser | missense_variant | Exon 2 of 4 | ENST00000258439.8 | NP_060319.1 | |
| TMEM127 | NM_001193304.3 | c.158G>C | p.Trp53Ser | missense_variant | Exon 2 of 4 | NP_001180233.1 | ||
| TMEM127 | NM_001407283.1 | c.-9+645G>C | intron_variant | Intron 1 of 2 | NP_001394212.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| TMEM127 | ENST00000258439.8 | c.158G>C | p.Trp53Ser | missense_variant | Exon 2 of 4 | 1 | NM_017849.4 | ENSP00000258439.3 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152254Hom.: 0 Cov.: 32 show subpopulations
GnomAD4 exome AF: 6.89e-7 AC: 1AN: 1451464Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 721704 show subpopulations
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152254Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74384 show subpopulations
ClinVar
Submissions by phenotype
Pheochromocytoma Pathogenic:1Uncertain:1
- -
- -
Hereditary cancer-predisposing syndrome Pathogenic:1
The p.W53S variant (also known as c.158G>C), located in coding exon 1 of the TMEM127 gene, results from a G to C substitution at nucleotide position 158. The tryptophan at codon 53 is replaced by serine, an amino acid with highly dissimilar properties. This variant has been observed in multiple individuals with a personal and/or family history of pheochromocytoma (Ambry internal data; Yao L et al. JAMA, 2010 Dec;304:2611-9). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). Based on the majority of available evidence to date, this variant is likely to be pathogenic. -
Hereditary pheochromocytoma-paraganglioma Uncertain:1
This sequence change replaces tryptophan, which is neutral and slightly polar, with serine, which is neutral and polar, at codon 53 of the TMEM127 protein (p.Trp53Ser). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with pheochromocytomas and/or paragangliomas (PMID: 21156949, 22136840). ClinVar contains an entry for this variant (Variation ID: 126963). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at